Inventor · disambiguated record
Lawrence G. Lum
Also filed as: LUM LAWRENCE · LUM LAWRENCE G
16 granted patents·24 pending applications·95 citations·filing 2002–2025
90Inventor score
Files withTRANSTARGET INC7UNIV TEXAS7UNIV PENNSYLVANIA4UNIV VIRGINIA PATENT FOUNDATION4LUM LAWRENCE3
Top patents by PatentIndex Score
40 records- 0190US11890301B2Methods and compositions for cells expressing a chimeric intracellular signaling moleculeUNIV PENNSYLVANIA·Filed 2016·Granted Feb 6, 2024·4 cites·8 claims
- 0290US7576186B2Compositions and methods for stem cell deliveryROGER WILLIAMS HOSPITAL·Filed 2003·Granted Aug 18, 2009·18 cites·2 claims
- 0387US11667721B2CD30 bispecific antibodies and method of immunotherapy of CD30+ malignanciesMEDICAL COLLEGE OF WISCONSIN INC·Filed 2019·Granted Jun 6, 2023·4 cites·17 claims
- 0487US7763243B2In situ immunizationROGER WILLIAMS MEDICAL CT·Filed 2002·Granted Jul 27, 2010·55 cites·81 claims
- 0583US9783550B2Highly potent inhibitors of porcupineUNIV TEXAS·Filed 2014·Granted Oct 10, 2017·3 cites·19 claims
- 0683US8999398B2Polyclonal bispecific antibody compositions and method of useLUM LAWRENCE·Filed 2010·Granted Apr 7, 2015·5 cites·17 claims
- 0779US8445491B2Wnt protein signalling inhibitorsLUM LAWRENCE·Filed 2009·Granted May 21, 2013·6 cites·11 claims
- 0879US2025346680A1System and method for the development of cd30 bispecific antibodies for immunotherapy of cd30+ malignanciesMEDICAL COLLEGE OF WISCONSIN INC·Filed 2025·Application pending·0 cites
- 0976US12391764B2Anti-CD30 and anti-CD3 bispecific antibodies and methods of immunotherapy for CD30+ malignanciesMEDICAL COLLEGE OF WISCONSIN INC·Filed 2023·Granted Aug 19, 2025·0 cites·34 claims
- 1075US2024342213A1Methods and Compositions for Cells Expressing a Chimeric Intracellular Signaling MoleculeUNIV PENNSYLVANIA·Filed 2024·Application pending·0 cites
- 1172US2024026293A1Methods and Compositions for Cells Expressing a Chimeric Intracellular Signaling MoleculeUNIV PENNSYLVANIA·Filed 2023·Application pending·0 cites
- 1267US2010055115A1Compositions and methods for stem cell deliveryLUM LAWRENCE G·Filed 2009·Application pending·0 cites
- 1366US2013224206A1Compositions and methods for stem cell deliveryTRANS TARGET INC·Filed 2013·Application pending·0 cites
- 1462US2025319127A1Bispecific antibodiesHUANG MANLEY·Filed 2022·Application pending·0 cites
- 1561US2024415890A1Infusion of fresh immune effector cells armed with multispecific antibodyUNIV VIRGINIA PATENT FOUNDATION·Filed 2022·Application pending·0 cites
- 1661US2014329310A1Activated T CellsLUM LAWRENCE G·Filed 2014·Application pending·0 cites
- 1758US2012121599A1Compositions and methods for stem cell deliveryLUM LAWRENCE G·Filed 2012·Application pending·0 cites
- 1858US2009068181A1Bispecific antibodiesTRANSTARGET INC·Filed 2008·Application pending·0 cites
- 1958US2011002930A1Activated T CellsUNIV WAYNE STATE·Filed 2008·Application pending·0 cites
- 2057US11649435B2Methods and compositions for cells expressing a chimeric intracellular signaling moleculeUNIV PENNSYLVANIA·Filed 2016·Granted May 16, 2023·0 cites·19 claims
- 2156US9045416B2WNT protein signalling inhibitorsUNIV TEXAS·Filed 2013·Granted Jun 2, 2015·0 cites·6 claims
- 2255US2018298088A1Compositions and methods for stem cell deliveryTRANSTARGET INC·Filed 2018·Application pending·0 cites
- 2354US2017073402A1Compositions and methods for stem cell deliveryTRANSTARGET INC·Filed 2016·Application pending·0 cites
- 2453US2012076786A1Bispecific antibodiesLEE RANDALL J·Filed 2011·Application pending·0 cites
- 2552US12006511B2Recombinant PD-L1 peptides and methods of useMEDICAL COLLEGE WISCONSIN INC·Filed 2020·Granted Jun 11, 2024·0 cites·15 claims
- 2651US2022273718A1Bispecific antibody targeting of t regulatory cells for treatment of inflammatory conditionsUNIV VIRGINIA PATENT FOUNDATION·Filed 2020·Application pending·0 cites
- 2750US2006018897A1Bispecific antibodiesTRANSTARGET INC·Filed 2005·Application pending·0 cites
- 2850US2022175836A1Priming with targeted activated t cells can enhance chemo responsiveness of cancer cellsUNIV VIRGINIA PATENT FOUNDATION·Filed 2020·Application pending·0 cites
- 2949US2023043806A1Induction of highly efficacious anti-tumor and immune modulating activity: cell-free off the shelf therapeutic modalityUNIV VIRGINIA PATENT FOUNDATION·Filed 2020·Application pending·0 cites
- 3047US9499619B2Polyclonal bispecific antibody compositions and method of useTRANSTARGET INC·Filed 2015·Granted Nov 22, 2016·0 cites·28 claims
- 3147US2015157633A1Wnt protein signalling inhibitorsUNIV TEXAS·Filed 2013·Application pending·0 cites
- 3247US2016237167A1Compositions and methods for stem cell deliveryTRANSTARGET INC·Filed 2015·Application pending·0 cites
- 3344US2018353622A1Gene deletion and rescue by crispr-mediated elimination of exon splicing enhancersUNIV TEXAS·Filed 2018·Application pending·0 cites
- 3442US12324836B2Methods and compositions for vaccinating and boosting cancer patientsTRANSTARGET INC·Filed 2017·Granted Jun 10, 2025·0 cites·14 claims
- 3542US2006034767A1Targeting and tracking of cells to specific organs and tissues in vivoROGER WILLIAMS MEDICAL CT·Filed 2003·Application pending·0 cites
- 3642US2015374696A1Wnt protein signalling inhibitorsUNIV TEXAS·Filed 2015·Application pending·0 cites
- 3741US10793544B2Disubstituted and trisubstituted 1,2,3-triazoles as Wnt inhibitorsUNIV TEXAS·Filed 2017·Granted Oct 6, 2020·0 cites·19 claims
- 3841US10420758B2Indolinyl-sulfonamide inhibitors of tankyrase and methods of use thereofUNIV TEXAS·Filed 2016·Granted Sep 24, 2019·0 cites·17 claims
- 3940US2011064689A1In situ immunizationROGER WILLIAMS MEDICAL CT·Filed 2010·Application pending·0 cites
- 4036US8569002B2Multiplexed luciferase reporter assay systemsLUM LAWRENCE·Filed 2010·Granted Oct 29, 2013·0 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when Lawrence G. Lum files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →